Reply to Humphries and Simner, "Verification Is an Integral Part of Antimicrobial Susceptibility Test Quality Assurance," and Wojewoda et al., "College of American Pathologists (CAP) Microbiology Committee Perspective: the Need for Verification Studies"
- PMID: 32213577
- PMCID: PMC7098772
- DOI: 10.1128/JCM.02062-19
Reply to Humphries and Simner, "Verification Is an Integral Part of Antimicrobial Susceptibility Test Quality Assurance," and Wojewoda et al., "College of American Pathologists (CAP) Microbiology Committee Perspective: the Need for Verification Studies"
References
-
- Clark RB, Lewisnski ML, Loeffelholtz MJ, Tibbets RJ. 2009. Cumitech 31A. Verification and validation of procedures in the clinical microbiology laboratory. Coordinating ed, Sharp SE.ASM Press, Washington, DC.
-
- CLSI. 2015. Verification of commercial microbial identification and antimicrobial susceptibility testing systems, 1st ed CLSI guideline M52 Clinical and Laboratory Standards Institute, Wayne, PA.
-
- US Food and Drug Administration. 2009. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems. FDA, Washington, DC: https://www.fda.gov/regulatory-information/search-fda-guidance-documents.... Accessed 27 July 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous